On the other hand, in the presence of oncogenic KRAS, KLK10 promotes tumor progression through the PAR1/PDK1/Akt axis, and it has also been linked to epithelial–mesenchymal transition via activation of the FAK/SRC/ERK pathway [240,241]. Here, KLK10 is linked to neoplasm.